These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24965038)

  • 1. AFM resolves effects of ethambutol on nanomechanics and nanostructures of single dividing mycobacteria in real-time.
    Wu Y; Sims RC; Zhou A
    Phys Chem Chem Phys; 2014 Sep; 16(36):19156-64. PubMed ID: 24965038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ, real-time tracking of cell wall topography and nanomechanics of antimycobacterial drugs treated Mycobacterium JLS using atomic force microscopy.
    Wu Y; Zhou A
    Chem Commun (Camb); 2009 Dec; (45):7021-3. PubMed ID: 19904381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethambutol-induced alterations in Mycobacterium bovis BCG imaged by atomic force microscopy.
    Verbelen C; Dupres V; Menozzi FD; Raze D; Baulard AR; Hols P; Dufrêne YF
    FEMS Microbiol Lett; 2006 Nov; 264(2):192-7. PubMed ID: 17064372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
    Korycka-Machała M; Rumijowska-Galewicz A; Dziadek J
    Pol J Microbiol; 2005; 54(1):5-11. PubMed ID: 16209089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethambutol-sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis.
    Reynolds RC; Bansal N; Rose J; Friedrich J; Suling WJ; Maddry JA
    Carbohydr Res; 1999 Apr; 317(1-4):164-79. PubMed ID: 10466213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuations in adhesion behavior of dividing/budding mycobacterium sp. strains JLS, KMS, MCS: an AFM evaluation.
    Wu Y; Zhou A
    Micron; 2010 Oct; 41(7):814-20. PubMed ID: 20538471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Ahmad S; Jaber AA; Mokaddas E
    Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of M. tuberculosis and atypical mycobacteria to ethambutol, capreomycin and rifampicin].
    Schröder KH; Hensel J; Scheuch V
    Prax Pneumol; 1969 Oct; 23(10):683-94. PubMed ID: 4984409
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of novel ethambutol analogues.
    Yendapally R; Lee RE
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1607-11. PubMed ID: 18242089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethambutol analogues as potential antimycobacterial agents.
    Häusler H; Kawakami RP; Mlaker E; Severn WB; Stütz AE
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1679-81. PubMed ID: 11425536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
    Neubert R
    Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mycobacterial growth by plumbagin derivatives.
    Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
    Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Ethambutol [d-2,2'-(ethylenediimino)-di-I-butanol] resistant mycobacteria grown in the absence of Ethambutol.
    Gupta SK; Mathur IS
    Indian J Exp Biol; 1965 Jul; 3(3):176-7. PubMed ID: 5320364
    [No Abstract]   [Full Text] [Related]  

  • 15. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in emb B gene of ethambutol resistant isolates of Mycobacterium tuberculosis: a preliminary report.
    Jain A; Mondal R; Srivastava S; Prasad R; Singh K; Ahuja RC
    Indian J Med Res; 2008 Nov; 128(5):634-9. PubMed ID: 19179685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains.
    Rapaport E; Levina A; Metelev V; Zamecnik PC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):709-13. PubMed ID: 8570621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.